InvestorsHub Logo
Followers 827
Posts 119469
Boards Moderated 15
Alias Born 09/05/2002

Re: jbog post# 17367

Wednesday, 06/21/2017 12:58:36 PM

Wednesday, June 21, 2017 12:58:36 PM

Post# of 20689
This statement by an FDA official about interchangeable FoBs is more pertinent to MNTA’s business model (which no longer includes development of small-molecule generics):


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”